Search for Stocks Search for IPO Search for Indices

Customer Portal

EMI Card

Download

Offers

BAJAJ FINSERV DIRECT LIMITED

Open Your FREE Demat Account Now!

Apply Now

Fundamentals Financials Shareholding About Company Peer Comparison Latest News FAQs

Nureca Ltd. Share Price

NSE

BSE

NSE : NURECA

BSE : 543264

Sector : Healthcare

N/A

indicator

1D

1M

3M

6M

1Y

5Y

Price Summary

Previous Close	₹235.65
Day's Range	₹232.30 - ₹245.45
Open	₹245.45
52 Week Range	₹204.00 - ₹343.00
Volume	15,396
Market Cap	₹0.00

Previous Close	₹233.70
Day's Range	₹230.00 - ₹238.75
Open	₹236.65
52 Week Range	₹200.10 - ₹343.60
Volume	1,210
Market Cap	₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs)	36.28
Market Cap (₹ in Mn)	0.00
Dividend Yield(%)	0.00
Price/Earning (TTM)	106.79
TTM EPS (₹)	2.18
P/E Ratio	248.64
Book Value(₹)	1.23
PAT Margin (%)	0.69
Face Value (₹)	10.00
ROCE(%)	1.31

Trade Value ( ₹ in Lacs)	2.83
Market Cap (₹ in Mn)	0.00
Dividend Yield(%)	0.00
Price/Earning (TTM)	106.79
TTM EPS (₹)	2.18
P/E Ratio	248.64
Book Value(₹)	1.23
PAT Margin (%)	0.69
Face Value (₹)	10.00
ROCE(%)	1.31

Financials

Particulars	QTR FY (₹ in Millions)	Annual FY (₹ in Millions)
Net sales	1146.4	317.4
Expenses	N/A	N/A
PBT	-4.6	20.51
Operating profit	0.0	0.0
Net profit	-6.68	24.67

Shareholding Pattern

Promoters (% Holding)

68.09%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

31.43%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.28%

About Nureca Ltd.

Founded	2016
Managing Director	Saurabh Goyal
NSE Symbol	NURECA

Peer Comparision

Stocks Name	Market Cap (Cr)(₹)	Market Price (₹)	52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd.	4,33,619.81	1,800.00	1,548.00 - 1,548.00
Divi's Laboratories Ltd.	1,76,086.64	6,608.15	5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd.	1,54,837.10	4,508.95	3,140.10 - 3,140.10
Apollo Hospitals Enterprise Ltd.	1,22,165.91	8,464.75	6,696.50 - 6,696.50
Cipla Ltd.	1,12,193.56	1,382.00	1,165.70 - 1,165.70
Zydus Lifesciences Ltd.	1,11,123.45	1,090.45	835.50 - 835.50
Dr. Reddy's Laboratories Ltd.	1,06,328.49	1,280.00	1,148.40 - 1,148.40
Lupin Ltd.	1,04,829.70	2,268.70	1,836.80 - 1,836.80
Max Healthcare Institute Ltd.	98,511.74	1,026.55	903.00 - 903.00
Mankind Pharma Ltd.	98,270.33	2,381.10	1,909.70 - 1,909.70

Latest News

Jun

10

2026

EQUITY Posted on Jun 10^th 2026

Nureca informs about disclosure

Nureca has informed it enclosed disclosure received from Nectar Biopharma, Member of Promoter Group pursuant to Regulation 7(2) of PIT Regulations in respect of disposal of shares of the company through an off-market transaction. The disclosure is not required vide SEBI Circular No. SEBI/HO/ISD/ISD/CIR/P/2020/168 and SEBI/HO/ISD/ISD/CIR/P/2021/617 dated September 09, 2020 and August 13, 2021 respectively.

The above information is a part of company’s filings submitted to BSE.

Read More

Jun

15

2026

EQUITY Posted on Jun 15^th 2026

Chennai Meenakshi Multispeciality Hospital informs about resignation of CEO

Chennai Meenakshi Multispeciality Hospital has informed that Venkataraman Krishnamurthy vide his letter dated 15th June 2026 has tendered his resignation as Chief Executive Officer of the Company with effect from close of business hours on 15th June 2026 due to his personal reasons.

The above information is a part of company’s filings submitted to BSE.

Read More

Jun

15

2026

EQUITY Posted on Jun 15^th 2026

Granules India informs about analyst meet

Pursuant to provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Granules India has informed that the officials of the Company will be meeting the Analysts/Investors/Funds at ‘IIFL Invest India Conference – London at London on June 23, 2026 & June 24,2026 (One-to-one & Group). No unpublished price-sensitive information is proposed to be shared by the Company during the meetings above. The latest Investor Presentation is available on the website of the Company: https://granulesindia.com/investors/investor-resources/investor-presentation/.

The above information is a part of company’s filings submitted to BSE.

Read More

Jun

15

2026

EQUITY Posted on Jun 15^th 2026

Gujarat Inject Kerala informs about media release

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Inject Kerala has informed that it enclosed the Media Release titled ‘Gujarat Inject Kerala Limited Bags Rs. 14.49 Crore Solar PV Module Order from Deon Energy Limited.’

The above information is a part of company’s filings submitted to BSE.

Read More

Jun

15

2026

EQUITY Posted on Jun 15^th 2026

Ajanta Pharma informs about AGM

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ajanta Pharma has informed that: a. The Forty-Seventh Annual General Meeting (‘AGM’) of the Members of the Company will be held on Thursday, 16th July 2026 at 11:00 am (IST) through Video Conferencing (‘VC’) / Other Audio-Visual Means (‘OAVM’), in compliance with the applicable provisions of the Companies Act, 2013 and the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. b. For the purpose of dispatch of the Annual Report for FY 2025-26 and the Notice convening the 47th AGM, the beneficiary position of shareholders as received from the Depositories as on Friday, 12th June 2026 will be considered. c. The cut-off date for determining the eligibility of Members to vote on the resolutions proposed to be passed at the 47th AGM shall be Thursday, 9th July 2026. The Notice convening the AGM and the Annual Report for FY 2025-26 will be dispatched to the Members in due course and will also be made available on the website of the Company.

The above information is a part of company’s filings submitted to BSE.

Read More

Sign in to Unlock Offers!

STEP 1/2

Open Demat Account today!

Mobile Number

Enter mobile number

Frequently Asked Questions

What is the current share price of Nureca Ltd. ?

The current share price of Nureca Ltd. is ₹235.65 as of 2026-06-15.

What is the Market Cap of Nureca Ltd. Share?

The market capitalisation of Nureca Ltd. is ₹222.33 as of 2026-06-12.

What is a 1 year return for Nureca Ltd. ?

The 1-year return of Nureca Ltd. is 3.55% as of 2026-06-15.

What is the P/E Ratio of Nureca Ltd. Share?

The P/E ratio of Nureca Ltd. is 248.64 as of 2026-06-15.

What is the 52 Week High and Low of Nureca Ltd. ?

The 52-week high and low of Nureca Ltd. are ₹343.00 and ₹204.00, respectively, as of 2026-06-15.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.

STEP 1/2

Open a Demat Account today!

Mobile Number Enter Valid Mobile Number

Indices : Nifty 50 Nifty Bank Nifty Financial Services Nifty Next 50 Nifty Midcap 100 BSE Sensex India Vix

Stocks : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Home

Shopping

Loan Offers

My Accounts

Explore